Insight journal - Company

Genzyme: Company Profile

Posted on 01 February 2012

Tags: ,

Genzyme, a pioneer in the development and delivery of transformative therapies for over 30 years, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years.

Return to top 50 pharma list

Summary

Website: Genzyme

Headquarters: Massachusetts, USA

Ticker Symbol: GEZ (Frankfurt Stock Exchange) GENZ (Nasdaq Stock Exchange)

SEC Link: Genzyme

Premium content locked

Premium content

The remaining part of this article is Premium content – see below for access options.

CP Insight – Premium content section

This is a premium content section and requires a paid subscription to access.

Please login to read the full article or take a look at the subscribe page for more information on prices.

LOG IN or CONTACT US

Already a subscriber?

Access to this area requires a CP Insight subscription.

Login for complete access

Subscription options

View for more information on pricing

Have a question?

Contact us

Print Friendly, PDF & Email

Leave a Reply